Form 8-K - Current report:
SEC Accession No. 0001070081-22-000015
Filing Date
2022-05-03
Accepted
2022-05-03 16:02:21
Documents
14
Period of Report
2022-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ptct-20220503x8k.htm   iXBRL 8-K 44173
2 EX-99.1 ptct-20220503ex991887252.htm EX-99.1 155349
3 GRAPHIC ptct-20220503ex991887252001.jpg GRAPHIC 6032
  Complete submission text file 0001070081-22-000015.txt   340706

Data Files

Seq Description Document Type Size
4 EX-101.SCH ptct-20220503.xsd EX-101.SCH 3041
5 EX-101.LAB ptct-20220503_lab.xml EX-101.LAB 15270
6 EX-101.PRE ptct-20220503_pre.xml EX-101.PRE 9662
8 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20220503x8k_htm.xml XML 4630
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 22886737
SIC: 2834 Pharmaceutical Preparations